Lubberman F, Gelderblom H, Hamberg P, et al. A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs? ASCO Annual Meeting 2019, abstract 4564.
Nivolumab-relatlimab (Opdualag) voor behandeling huidkanker niet in basispakket
jun 2024 | Dermato-oncologie, Immuuntherapie